Key facts
- This page summarizes Troy E. Wilson's Form 4 filing for Kura Oncology, Inc. (KURA).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 06 Jan 2026, 16:31.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
This option vests in 48 equal monthly installments commencing on the grant date.